Midgard Science

UGA Biopharma

Hennigsdorf, Germany ugabiopharma.com From their website, Nov 2026

  • ISO 9001

Work here? Claim this listing

About

UGA Biopharma develops cell lines, upstream and downstream processes, and analytical methods for biologics and biosimilars. It also offers ready-to-use CHO-based cell lines and proprietary CHO Prime media and feed products. The company is based in Hennigsdorf near Berlin, Germany, and works with customers in biopharmaceutical development.

Services

  • Cell Line Development (CLD)

    Develops stable, high-performance cell lines using proprietary expression vectors, adapted CHO host cells, cloning, screening, stability studies, and cell bank generation.

    Cell line development

  • Upstream Processing (USP)

    Develops and optimizes scalable upstream bioprocesses, from small-scale clone screening in Ambr 15 bioreactors to cultivation in 5-litre bioreactors.

    Cell line development

  • Downstream Processing (DSP)

    Develops customized, scalable protein purification processes using chromatographic methods and product-quality monitoring throughout purification.

    Cell line development

  • Analytical Development

    Develops analytical procedures to monitor critical quality attributes and characterize bioprocess performance and product quality.

  • Ready-to-Use cell lines (R2U-Cells)

    Provides ready-to-use CHO-based cell lines for biosimilar expression, including lines for recombinant enzymes referenced on the site.

    Cell line development

  • CHO Prime media and feeds

    Provides proprietary CHO Prime media and matched feed products for cell culture and fed-batch cultivation.

  • Analytical Method Development

    Develops analysis methods to determine productivity and critical quality attributes.

  • Ready-to-Use (R2U) cell lines

    Provides ready-to-use CHO cell lines for biosimilars, including cell lines expressing specific recombinant enzymes.

    Cell line development

1 more services
  • CHO Prime® Media & Feeds
What to send
  • Gene synthesis and cloning into proprietary expression vectors
  • Detailed documentation in line with regulatory requirements

Capabilities

Assays and studies
  • CHO
  • Analytical development
  • Charge variant analysis
  • N-glycan analysis
  • Ion exchange chromatography
  • HILIC chromatography
10 more
  • Hydrophobic interaction chromatography
  • Size exclusion chromatography
  • Peptide mapping
  • SDS-PAGE
  • Western blotting
  • ELISA
  • In-vitro activity testing
  • LC-MS
  • Analytical method development
  • Critical quality attribute (CQA) monitoring
Scale and capacity
  • Parallel experiments on a small scale
  • 5-litre bioreactors
  • 96-well filter plates
  • Column format
Therapeutic areas
  • Rare diseases
  • Pompe disease
  • Mucopolysaccharidosis type VI

Instruments and platforms

  • Ambr 15 bioreactors
  • FPLC (ÄKTA)
  • UF/DF systems

Modalities and species

Modalities
  • Antibody
  • Peptide
  • Recombinant protein
  • Biosimilar
Species and models
  • CHO cells
  • CHO-DG44
  • CHO-K1
  • CHO-DXB11
  • CHO

Certifications

As the company states them, with the certificate or registry record where there is one.

  • ISO 9001Self-reported

Industries served

  • Biologics
  • Biosimilars
  • Biopharmaceuticals

Details

Type
CRO
Founded
2009
Address
Neuendorfstraße 20a 16761 Hennigsdorf (bei Berlin)
Serves
International, worldwide
Phone
+49 3302 / 20 24 900

Similar labs